Cargando…

Calprotectin, Biomarker of Depression in Patients with Inflammatory Bowel Disease?

Background and Objectives: Calprotectin is a marker for intestinal inflammation. Recent research suggests a link between inflammation and depression. This study assessed the association between the levels of calprotectin in patients from South-Eastern Europe and the severity of depression, anxiety,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Iordache, Miorita Melina, Belu, Anca Mihaela, Vlad, Sabina E., Aivaz, Kamer Ainur, Dumitru, Andrei, Tocia, Cristina, Dumitru, Eugen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10383955/ https://www.ncbi.nlm.nih.gov/pubmed/37512053 http://dx.doi.org/10.3390/medicina59071240

Ejemplares similares

Depression in Central and Eastern Europe: How Much It Costs? Cost of Depression in Romania
por: Iordache, Miorita Melina, et al.
Publicado: (2023)

Intestinal Permeability and Depression in Patients with Inflammatory Bowel Disease
por: Iordache, Miorita Melina, et al.
Publicado: (2022)

Does rifaximin offer any promise in Crohn's disease in remission and concurrent irritable bowel syndrome-like symptoms?
por: Tocia, Cristina, et al.
Publicado: (2021)

Timing of paracentesis and outcomes in hospitalized patients with decompensated cirrhosis
por: Tocia, Cristina, et al.
Publicado: (2020)

Association of TCF7L2, CASC8 and GREM1 Polymorphisms in Patients with Colorectal Cancer and Type II Diabetes Mellitus
por: Mitroi, Anca Florentina, et al.
Publicado: (2022)

Influence of type II diabetes mellitus on postoperative complications following colorectal cancer surgery
por: Popescu, Răzvan Cătălin, et al.
Publicado: (2022)

TCF7L2, CASC8, and GREM1 polymorphism and colorectal cancer in south-eastern Romanian population
por: Mitroi, Anca Florentina, et al.
Publicado: (2023)

Molecular profiling of the colon cancer in South-Eastern Romania: Results from the MERCUR study
por: Popescu, Razvan Catalin, et al.
Publicado: (2021)

College Students’ Distractions from Learning Caused by Multitasking in Online vs. Face-to-Face Classes: A Case Study at a Public University in Romania
por: Aivaz, Kamer Ainur, et al.
Publicado: (2022)

Calprotectin in inflammatory bowel disease
por: Khaki-Khatibi, Fatemeh, et al.
Publicado: (2020)

Using Dancesport as an Educational Resource for Improving Institutionalized Children’s Learning Strategies
por: Tomescu, Gabriela, et al.
Publicado: (2023)

Fecal calprotectin in inflammatory bowel disease
por: Walsham, Natalie E, et al.
Publicado: (2016)

Extended Lymphadenectomy for Proximal Transverse Colon Cancer: Is There a Place for Standardization?
por: Popescu, Răzvan Cătălin, et al.
Publicado: (2022)

Combined Use of Fecal Biomarkers in Inflammatory Bowel Diseases: Oncostatin M and Calprotectin
por: Cao, Ying, et al.
Publicado: (2021)

Usefulness of Faecal Calprotectin Measurement in Children with Various Types of Inflammatory Bowel Disease
por: Komraus, Marzena, et al.
Publicado: (2012)

The Role of Fecal Calprotectin in Investigating Inflammatory Bowel Diseases
por: Erbayrak, Mustafa, et al.
Publicado: (2009)

Measurement of faecal calprotectin and lactoferrin in inflammatory bowel disease
por: Lamb, C A, et al.
Publicado: (2011)

Fecal Calprotectin for the Diagnosis and Management of Inflammatory Bowel Diseases
por: Kapel, Nathalie, et al.
Publicado: (2023)

Fecal immunochemical test as a biomarker for inflammatory bowel diseases: can it rival fecal calprotectin?
por: Kato, Jun, et al.
Publicado: (2016)

The role of serum calprotectin as a novel biomarker in inflammatory bowel diseases: a review study
por: Azramezani Kopi, Tayebeh, et al.
Publicado: (2019)

A98 FECAL LEUKOCYTE ESTERASE: AN ALTERNATIVE BIOMARKER TO FECAL CALPROTECTIN IN INFLAMMATORY BOWEL DISEASE
por: Klemm, N K, et al.
Publicado: (2022)

The usefulness of fecal calprotectin in assessing inflammatory bowel disease activity
por: Lee, Yang Woon, et al.
Publicado: (2019)

Prostaglandins and calprotectin are genetically and functionally linked to the Inflammatory Bowel Diseases
por: Karaky, Mohamad, et al.
Publicado: (2022)

FOCUS: Future of fecal calprotectin utility study in inflammatory bowel disease
por: Rosenfeld, Greg, et al.
Publicado: (2016)

The comparison of the three assays for determination of fecal calprotectin in inflammatory bowel disease
por: Osredkar, Joško, et al.
Publicado: (2021)

Does faecal calprotectin differentiate between inflammatory bowel disease colitis and non-inflammatory bowel disease colitides?
por: Khalil, Ahmed F., et al.
Publicado: (2020)

Accuracy of three different fecal calprotectin tests in the diagnosis of inflammatory bowel disease
por: Jang, Hui Won, et al.
Publicado: (2016)

Impact of Fecal Calprotectin Measurement on Decision-making in Children with Inflammatory Bowel Disease
por: El-Matary, Wael, et al.
Publicado: (2017)

From bench to bedside: Fecal calprotectin in inflammatory bowel diseases clinical setting
por: Mumolo, Maria Gloria, et al.
Publicado: (2018)

Detection of calprotectin in inflammatory bowel disease: Fecal and serum levels and immunohistochemical localization
por: Fukunaga, Shuhei, et al.
Publicado: (2018)

Comparison of Fecal Calprotectin Methods for Predicting Relapse of Pediatric Inflammatory Bowel Disease
por: Kittanakom, Saranya, et al.
Publicado: (2017)

Association of Fecal Calprotectin With Endoscopic and Histologic Activity in Pediatric Inflammatory Bowel Disease
por: Crawford, Erin, et al.
Publicado: (2021)

Faecal calprotectin for screening of patients with suspected inflammatory bowel disease: diagnostic meta-analysis
por: van Rheenen, Patrick F, et al.
Publicado: (2010)

A longitudinal study of fecal calprotectin and the development of inflammatory bowel disease in ankylosing spondylitis
por: Klingberg, Eva, et al.
Publicado: (2017)

Could fecal calprotectin enter mainstream use for diagnosing and monitoring inflammatory bowel disease?
por: Wei, Shu Chen
Publicado: (2016)

The Utility of Fecal Calprotectin in the Real-World Clinical Care of Patients with Inflammatory Bowel Disease
por: Abej, Esmail, et al.
Publicado: (2016)

Commentary: Impact of Fecal Calprotectin Measurement on Decision-Making in Children with Inflammatory Bowel Disease
por: Day, Andrew S., et al.
Publicado: (2017)

Cost-effectiveness of faecal calprotectin used in primary care in the diagnosis of inflammatory bowel disease
por: Zhang, Wei, et al.
Publicado: (2019)

Time-to-reach Target Calprotectin Level in Newly Diagnosed Patients With Inflammatory Bowel Disease
por: Haisma, Sjoukje-Marije, et al.
Publicado: (2019)

Fecal Calprotectin in Combination With Standard Blood Tests in the Diagnosis of Inflammatory Bowel Disease in Children
por: Ho, Shaun S. C., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ctl2pukkqga8n4ajddvnijifo3